Loading…

Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India

AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations includ...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2014-05, Vol.20 (17), p.5017-5024
Main Authors: Larsson, Geir, Shenoy, Thrivikrama, Ramasubramanian, Ramalingom, Balakumaran, Leena Kondarappassery, Småstuen, Milada Cvancarova, Bjune, Gunnar Aksel, Moum, Bjørn Allan
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-7f953283935d5d3fc27de215fb7cc4e64b34f4441cd200855481aca38c9c14693
cites
container_end_page 5024
container_issue 17
container_start_page 5017
container_title World journal of gastroenterology : WJG
container_volume 20
creator Larsson, Geir
Shenoy, Thrivikrama
Ramasubramanian, Ramalingom
Balakumaran, Leena Kondarappassery
Småstuen, Milada Cvancarova
Bjune, Gunnar Aksel
Moum, Bjørn Allan
description AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations included case history,physical examination,blood biochemistry,ileocolonoscopy and histopathological examination of biopsies.Patients were followed-up after 2 and 6 mo of treatment.The diagnosis of ITB or CD was re-evaluated after 2 mo of antituberculous chemotherapy or immune suppressive therapy respectively,based on improvement in signs,symptoms and laboratory variables.This study was considered to be an exploratory analysis.Clinical,endoscopic and histopathological features recorded at the time of inclusion were subject to univariate analyses.Disease variables with sufficient number of recordings and P<0.05 were entered into logistic regression models,adjusted for known confounders.Finally,we calculated the odds ratios with respective confidence intervals for variables associated with either ITB or CD.RESULTS:This study included 38 ITB and 37 CD patients.Overall,ITB patients had the lowest body mass index(19.6 vs 22.7,P=0.01)and more commonly reported weight loss(73%vs 38%,P<0.01),watery diarrhoea(64%vs 33%,P=0.01)and rural domicile(58%vs 35%,P<0.05).Endoscopy typically showed mucosal nodularity(17/31 vs 2/37,P<0.01)and histopathology more frequently showed granulomas(10/30vs 2/35,P<0.01).The CD patients more frequently reported malaise(87%vs 64%,P=0.03),nausea(84%vs 56%,P=0.01),pain in the right lower abdominal quadrant on examination(90%vs 54%,P<0.01)and urban domicile(65%vs 42%,P<0.05).In CD,endoscopy typically showed involvement of multiple intestinal segments(27/37 vs 9/31,P<0.01).Using logistic regression analysis we found weight loss and nodularity of the mucosa were independently associated with ITB,with adjusted odds ratios of 8.6(95%CI:2.1-35.6)and 18.9(95%CI:3.5-102.8)respectively.Right lower abdominal quadrant pain on examination and involvement of≥3 intestinal segments were independently associated with CD with adjusted odds ratios of 10.1(95%CI:2.0-51.3)and 5.9(95%CI:1.7-20.6),respectively.CONCLUSION:Weight loss and mucosal nodularity were associated with ITB.Abdominal pain and excessive intestinal involvement were associated with CD.ITB and CD were equally common.
doi_str_mv 10.3748/wjg.v20.i17.5017
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4009535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849524955485050</cqvip_id><sourcerecordid>24803814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-7f953283935d5d3fc27de215fb7cc4e64b34f4441cd200855481aca38c9c14693</originalsourceid><addsrcrecordid>eNpVkNtKAzEQhoMoth7uvZJ9ga2TZOImN4IUDwVB0Hod0mx2m9Jm62areOdr-Ho-ianWooEQmJn_G_IRckJhwAuUZ6-zevDCYOBpMRBAix3SZ4yqnEmEXdKnAEWuOCt65CDGGQDjXLB90mMogUuKfTJ-aFadDy4rvalDE33MmirzoXMxlc0861YT19rV_LtlQpkN22YaPt8_YopEZ6JL09ljokxdG7JRSKAjsleZeXTHm_eQPF1fjYe3-d39zWh4eZdbROjyolKCM8kVF6UoeWVZUTpGRTUprEV3jhOOFSJSWzIAKQRKaqzh0ipL8VzxQ3Lxw12uJgtXWhe61sz1svUL077pxnj9vxP8VNfNi0aAtFokAPwAbNvE2Lpqm6Wg14Z1MqyTYZ0M67XhFDn9u3Mb-FWaBviGOW1C_exDvZ1RINdHCUCJSrB0058ECOBfEGiKRQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India</title><source>PubMed Central</source><creator>Larsson, Geir ; Shenoy, Thrivikrama ; Ramasubramanian, Ramalingom ; Balakumaran, Leena Kondarappassery ; Småstuen, Milada Cvancarova ; Bjune, Gunnar Aksel ; Moum, Bjørn Allan</creator><creatorcontrib>Larsson, Geir ; Shenoy, Thrivikrama ; Ramasubramanian, Ramalingom ; Balakumaran, Leena Kondarappassery ; Småstuen, Milada Cvancarova ; Bjune, Gunnar Aksel ; Moum, Bjørn Allan</creatorcontrib><description><![CDATA[AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations included case history,physical examination,blood biochemistry,ileocolonoscopy and histopathological examination of biopsies.Patients were followed-up after 2 and 6 mo of treatment.The diagnosis of ITB or CD was re-evaluated after 2 mo of antituberculous chemotherapy or immune suppressive therapy respectively,based on improvement in signs,symptoms and laboratory variables.This study was considered to be an exploratory analysis.Clinical,endoscopic and histopathological features recorded at the time of inclusion were subject to univariate analyses.Disease variables with sufficient number of recordings and P&lt;0.05 were entered into logistic regression models,adjusted for known confounders.Finally,we calculated the odds ratios with respective confidence intervals for variables associated with either ITB or CD.RESULTS:This study included 38 ITB and 37 CD patients.Overall,ITB patients had the lowest body mass index(19.6 vs 22.7,P=0.01)and more commonly reported weight loss(73%vs 38%,P&lt;0.01),watery diarrhoea(64%vs 33%,P=0.01)and rural domicile(58%vs 35%,P&lt;0.05).Endoscopy typically showed mucosal nodularity(17/31 vs 2/37,P&lt;0.01)and histopathology more frequently showed granulomas(10/30vs 2/35,P&lt;0.01).The CD patients more frequently reported malaise(87%vs 64%,P=0.03),nausea(84%vs 56%,P=0.01),pain in the right lower abdominal quadrant on examination(90%vs 54%,P&lt;0.01)and urban domicile(65%vs 42%,P&lt;0.05).In CD,endoscopy typically showed involvement of multiple intestinal segments(27/37 vs 9/31,P&lt;0.01).Using logistic regression analysis we found weight loss and nodularity of the mucosa were independently associated with ITB,with adjusted odds ratios of 8.6(95%CI:2.1-35.6)and 18.9(95%CI:3.5-102.8)respectively.Right lower abdominal quadrant pain on examination and involvement of≥3 intestinal segments were independently associated with CD with adjusted odds ratios of 10.1(95%CI:2.0-51.3)and 5.9(95%CI:1.7-20.6),respectively.CONCLUSION:Weight loss and mucosal nodularity were associated with ITB.Abdominal pain and excessive intestinal involvement were associated with CD.ITB and CD were equally common.]]></description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v20.i17.5017</identifier><identifier>PMID: 24803814</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Co., Limited</publisher><subject>Abdominal Pain - diagnosis ; Antitubercular Agents - therapeutic use ; Biomarkers - blood ; Biopsy ; Brief ; Chi-Square Distribution ; Colonoscopy ; Confounding Factors (Epidemiology) ; Crohn Disease - blood ; Crohn Disease - diagnosis ; Crohn Disease - drug therapy ; Crohn Disease - pathology ; Diagnosis ; Diagnosis, Differential ; Differential ; Gastrointestin ; Humans ; Immunosuppressive Agents - therapeutic use ; India ; Intestinal Diseases - blood ; Intestinal Diseases - diagnosis ; Intestinal Diseases - drug therapy ; Intestinal Diseases - microbiology ; Intestinal Diseases - pathology ; Intestinal Mucosa - pathology ; Logistic Models ; Odds Ratio ; Pain Measurement ; Predictive Value of Tests ; Prospective Studies ; Time Factors ; Treatment Outcome ; Tuberculosis ; Tuberculosis, Gastrointestinal - blood ; Tuberculosis, Gastrointestinal - diagnosis ; Tuberculosis, Gastrointestinal - drug therapy ; Tuberculosis, Gastrointestinal - microbiology ; Tuberculosis, Gastrointestinal - pathology ; Weight Loss</subject><ispartof>World journal of gastroenterology : WJG, 2014-05, Vol.20 (17), p.5017-5024</ispartof><rights>2014 Baishideng Publishing Group Co., Limited. All rights reserved. 2014</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-7f953283935d5d3fc27de215fb7cc4e64b34f4441cd200855481aca38c9c14693</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009535/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009535/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24803814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Larsson, Geir</creatorcontrib><creatorcontrib>Shenoy, Thrivikrama</creatorcontrib><creatorcontrib>Ramasubramanian, Ramalingom</creatorcontrib><creatorcontrib>Balakumaran, Leena Kondarappassery</creatorcontrib><creatorcontrib>Småstuen, Milada Cvancarova</creatorcontrib><creatorcontrib>Bjune, Gunnar Aksel</creatorcontrib><creatorcontrib>Moum, Bjørn Allan</creatorcontrib><title>Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description><![CDATA[AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations included case history,physical examination,blood biochemistry,ileocolonoscopy and histopathological examination of biopsies.Patients were followed-up after 2 and 6 mo of treatment.The diagnosis of ITB or CD was re-evaluated after 2 mo of antituberculous chemotherapy or immune suppressive therapy respectively,based on improvement in signs,symptoms and laboratory variables.This study was considered to be an exploratory analysis.Clinical,endoscopic and histopathological features recorded at the time of inclusion were subject to univariate analyses.Disease variables with sufficient number of recordings and P&lt;0.05 were entered into logistic regression models,adjusted for known confounders.Finally,we calculated the odds ratios with respective confidence intervals for variables associated with either ITB or CD.RESULTS:This study included 38 ITB and 37 CD patients.Overall,ITB patients had the lowest body mass index(19.6 vs 22.7,P=0.01)and more commonly reported weight loss(73%vs 38%,P&lt;0.01),watery diarrhoea(64%vs 33%,P=0.01)and rural domicile(58%vs 35%,P&lt;0.05).Endoscopy typically showed mucosal nodularity(17/31 vs 2/37,P&lt;0.01)and histopathology more frequently showed granulomas(10/30vs 2/35,P&lt;0.01).The CD patients more frequently reported malaise(87%vs 64%,P=0.03),nausea(84%vs 56%,P=0.01),pain in the right lower abdominal quadrant on examination(90%vs 54%,P&lt;0.01)and urban domicile(65%vs 42%,P&lt;0.05).In CD,endoscopy typically showed involvement of multiple intestinal segments(27/37 vs 9/31,P&lt;0.01).Using logistic regression analysis we found weight loss and nodularity of the mucosa were independently associated with ITB,with adjusted odds ratios of 8.6(95%CI:2.1-35.6)and 18.9(95%CI:3.5-102.8)respectively.Right lower abdominal quadrant pain on examination and involvement of≥3 intestinal segments were independently associated with CD with adjusted odds ratios of 10.1(95%CI:2.0-51.3)and 5.9(95%CI:1.7-20.6),respectively.CONCLUSION:Weight loss and mucosal nodularity were associated with ITB.Abdominal pain and excessive intestinal involvement were associated with CD.ITB and CD were equally common.]]></description><subject>Abdominal Pain - diagnosis</subject><subject>Antitubercular Agents - therapeutic use</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>Brief</subject><subject>Chi-Square Distribution</subject><subject>Colonoscopy</subject><subject>Confounding Factors (Epidemiology)</subject><subject>Crohn Disease - blood</subject><subject>Crohn Disease - diagnosis</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - pathology</subject><subject>Diagnosis</subject><subject>Diagnosis, Differential</subject><subject>Differential</subject><subject>Gastrointestin</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>India</subject><subject>Intestinal Diseases - blood</subject><subject>Intestinal Diseases - diagnosis</subject><subject>Intestinal Diseases - drug therapy</subject><subject>Intestinal Diseases - microbiology</subject><subject>Intestinal Diseases - pathology</subject><subject>Intestinal Mucosa - pathology</subject><subject>Logistic Models</subject><subject>Odds Ratio</subject><subject>Pain Measurement</subject><subject>Predictive Value of Tests</subject><subject>Prospective Studies</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Gastrointestinal - blood</subject><subject>Tuberculosis, Gastrointestinal - diagnosis</subject><subject>Tuberculosis, Gastrointestinal - drug therapy</subject><subject>Tuberculosis, Gastrointestinal - microbiology</subject><subject>Tuberculosis, Gastrointestinal - pathology</subject><subject>Weight Loss</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKAzEQhoMoth7uvZJ9ga2TZOImN4IUDwVB0Hod0mx2m9Jm62areOdr-Ho-ianWooEQmJn_G_IRckJhwAuUZ6-zevDCYOBpMRBAix3SZ4yqnEmEXdKnAEWuOCt65CDGGQDjXLB90mMogUuKfTJ-aFadDy4rvalDE33MmirzoXMxlc0861YT19rV_LtlQpkN22YaPt8_YopEZ6JL09ljokxdG7JRSKAjsleZeXTHm_eQPF1fjYe3-d39zWh4eZdbROjyolKCM8kVF6UoeWVZUTpGRTUprEV3jhOOFSJSWzIAKQRKaqzh0ipL8VzxQ3Lxw12uJgtXWhe61sz1svUL077pxnj9vxP8VNfNi0aAtFokAPwAbNvE2Lpqm6Wg14Z1MqyTYZ0M67XhFDn9u3Mb-FWaBviGOW1C_exDvZ1RINdHCUCJSrB0058ECOBfEGiKRQ</recordid><startdate>20140507</startdate><enddate>20140507</enddate><creator>Larsson, Geir</creator><creator>Shenoy, Thrivikrama</creator><creator>Ramasubramanian, Ramalingom</creator><creator>Balakumaran, Leena Kondarappassery</creator><creator>Småstuen, Milada Cvancarova</creator><creator>Bjune, Gunnar Aksel</creator><creator>Moum, Bjørn Allan</creator><general>Baishideng Publishing Group Co., Limited</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140507</creationdate><title>Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India</title><author>Larsson, Geir ; Shenoy, Thrivikrama ; Ramasubramanian, Ramalingom ; Balakumaran, Leena Kondarappassery ; Småstuen, Milada Cvancarova ; Bjune, Gunnar Aksel ; Moum, Bjørn Allan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-7f953283935d5d3fc27de215fb7cc4e64b34f4441cd200855481aca38c9c14693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Abdominal Pain - diagnosis</topic><topic>Antitubercular Agents - therapeutic use</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>Brief</topic><topic>Chi-Square Distribution</topic><topic>Colonoscopy</topic><topic>Confounding Factors (Epidemiology)</topic><topic>Crohn Disease - blood</topic><topic>Crohn Disease - diagnosis</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - pathology</topic><topic>Diagnosis</topic><topic>Diagnosis, Differential</topic><topic>Differential</topic><topic>Gastrointestin</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>India</topic><topic>Intestinal Diseases - blood</topic><topic>Intestinal Diseases - diagnosis</topic><topic>Intestinal Diseases - drug therapy</topic><topic>Intestinal Diseases - microbiology</topic><topic>Intestinal Diseases - pathology</topic><topic>Intestinal Mucosa - pathology</topic><topic>Logistic Models</topic><topic>Odds Ratio</topic><topic>Pain Measurement</topic><topic>Predictive Value of Tests</topic><topic>Prospective Studies</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Gastrointestinal - blood</topic><topic>Tuberculosis, Gastrointestinal - diagnosis</topic><topic>Tuberculosis, Gastrointestinal - drug therapy</topic><topic>Tuberculosis, Gastrointestinal - microbiology</topic><topic>Tuberculosis, Gastrointestinal - pathology</topic><topic>Weight Loss</topic><toplevel>online_resources</toplevel><creatorcontrib>Larsson, Geir</creatorcontrib><creatorcontrib>Shenoy, Thrivikrama</creatorcontrib><creatorcontrib>Ramasubramanian, Ramalingom</creatorcontrib><creatorcontrib>Balakumaran, Leena Kondarappassery</creatorcontrib><creatorcontrib>Småstuen, Milada Cvancarova</creatorcontrib><creatorcontrib>Bjune, Gunnar Aksel</creatorcontrib><creatorcontrib>Moum, Bjørn Allan</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Larsson, Geir</au><au>Shenoy, Thrivikrama</au><au>Ramasubramanian, Ramalingom</au><au>Balakumaran, Leena Kondarappassery</au><au>Småstuen, Milada Cvancarova</au><au>Bjune, Gunnar Aksel</au><au>Moum, Bjørn Allan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2014-05-07</date><risdate>2014</risdate><volume>20</volume><issue>17</issue><spage>5017</spage><epage>5024</epage><pages>5017-5024</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract><![CDATA[AIM:To investigate whether routinely measured clinical variables could aid in differentiating intestinal tuberculosis(ITB)from Crohn’s disease(CD).METHODS:ITB and CD patients were prospectively included at four South Indian medical centres from October 2009 to July 2012.Routine investigations included case history,physical examination,blood biochemistry,ileocolonoscopy and histopathological examination of biopsies.Patients were followed-up after 2 and 6 mo of treatment.The diagnosis of ITB or CD was re-evaluated after 2 mo of antituberculous chemotherapy or immune suppressive therapy respectively,based on improvement in signs,symptoms and laboratory variables.This study was considered to be an exploratory analysis.Clinical,endoscopic and histopathological features recorded at the time of inclusion were subject to univariate analyses.Disease variables with sufficient number of recordings and P&lt;0.05 were entered into logistic regression models,adjusted for known confounders.Finally,we calculated the odds ratios with respective confidence intervals for variables associated with either ITB or CD.RESULTS:This study included 38 ITB and 37 CD patients.Overall,ITB patients had the lowest body mass index(19.6 vs 22.7,P=0.01)and more commonly reported weight loss(73%vs 38%,P&lt;0.01),watery diarrhoea(64%vs 33%,P=0.01)and rural domicile(58%vs 35%,P&lt;0.05).Endoscopy typically showed mucosal nodularity(17/31 vs 2/37,P&lt;0.01)and histopathology more frequently showed granulomas(10/30vs 2/35,P&lt;0.01).The CD patients more frequently reported malaise(87%vs 64%,P=0.03),nausea(84%vs 56%,P=0.01),pain in the right lower abdominal quadrant on examination(90%vs 54%,P&lt;0.01)and urban domicile(65%vs 42%,P&lt;0.05).In CD,endoscopy typically showed involvement of multiple intestinal segments(27/37 vs 9/31,P&lt;0.01).Using logistic regression analysis we found weight loss and nodularity of the mucosa were independently associated with ITB,with adjusted odds ratios of 8.6(95%CI:2.1-35.6)and 18.9(95%CI:3.5-102.8)respectively.Right lower abdominal quadrant pain on examination and involvement of≥3 intestinal segments were independently associated with CD with adjusted odds ratios of 10.1(95%CI:2.0-51.3)and 5.9(95%CI:1.7-20.6),respectively.CONCLUSION:Weight loss and mucosal nodularity were associated with ITB.Abdominal pain and excessive intestinal involvement were associated with CD.ITB and CD were equally common.]]></abstract><cop>United States</cop><pub>Baishideng Publishing Group Co., Limited</pub><pmid>24803814</pmid><doi>10.3748/wjg.v20.i17.5017</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2014-05, Vol.20 (17), p.5017-5024
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4009535
source PubMed Central
subjects Abdominal Pain - diagnosis
Antitubercular Agents - therapeutic use
Biomarkers - blood
Biopsy
Brief
Chi-Square Distribution
Colonoscopy
Confounding Factors (Epidemiology)
Crohn Disease - blood
Crohn Disease - diagnosis
Crohn Disease - drug therapy
Crohn Disease - pathology
Diagnosis
Diagnosis, Differential
Differential
Gastrointestin
Humans
Immunosuppressive Agents - therapeutic use
India
Intestinal Diseases - blood
Intestinal Diseases - diagnosis
Intestinal Diseases - drug therapy
Intestinal Diseases - microbiology
Intestinal Diseases - pathology
Intestinal Mucosa - pathology
Logistic Models
Odds Ratio
Pain Measurement
Predictive Value of Tests
Prospective Studies
Time Factors
Treatment Outcome
Tuberculosis
Tuberculosis, Gastrointestinal - blood
Tuberculosis, Gastrointestinal - diagnosis
Tuberculosis, Gastrointestinal - drug therapy
Tuberculosis, Gastrointestinal - microbiology
Tuberculosis, Gastrointestinal - pathology
Weight Loss
title Routine diagnosis of intestinal tuberculosis and Crohn’s disease in Southern India
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A45%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Routine%20diagnosis%20of%20intestinal%20tuberculosis%20and%20Crohn%E2%80%99s%20disease%20in%20Southern%20India&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Larsson,%20Geir&rft.date=2014-05-07&rft.volume=20&rft.issue=17&rft.spage=5017&rft.epage=5024&rft.pages=5017-5024&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v20.i17.5017&rft_dat=%3Cpubmed_cross%3E24803814%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-7f953283935d5d3fc27de215fb7cc4e64b34f4441cd200855481aca38c9c14693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/24803814&rft_cqvip_id=90888889504849524955485050&rfr_iscdi=true